| FBBAX | FIFAX | FBBAX / FIFAX | |
| Total Expense Ratio | 1.32 | 0.26 | 508% |
| Annual Report Gross Expense Ratio | 1.32 | 0.26 | 508% |
| Fund Existence | 34 years | 10 years | - |
| Gain YTD | -1.520 | 8.560 | -18% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 1000 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 61.5M | 150B | 0% |
| Annual Yield % from dividends | 3.74 | 3.65 | 102% |
| Returns for 1 year | -3.91 | 5.25 | -74% |
| Returns for 3 years | 4.03 | 38.78 | 10% |
| Returns for 5 years | 0.18 | 26.32 | 1% |
| Returns for 10 years | 53.79 | N/A | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| FBDIX | 197.86 | N/A | N/A |
| Franklin Biotechnology Discovery A | |||
| MRFGX | 15.46 | N/A | N/A |
| BlackRock Capital Appreciation R | |||
| FSPTX | 54.43 | N/A | N/A |
| Fidelity Select Technology | |||
| BCREX | 16.09 | N/A | N/A |
| BlackRock Real Estate Securities Inv C | |||
| MCEFX | 12.47 | -0.05 | -0.40% |
| BlackRock International Select Eq Inv C | |||